A phase II randomized clinical trial on cerebral near-infrared spectroscopy plus a treatment guideline versus treatment as usual for extremely preterm infants during the first three days of life (SafeBoosC): study protocol for a randomized controlled trial.

  • Simon Hyttel-Sorensen
  • , Topun Austin
  • , Frank van Bel
  • , Manon Benders
  • , Olivier Claris
  • , Eugene Dempsey
  • , Monica Fumagalli
  • , Gorm Greisen
  • , Berit Grevstad
  • , Cornelia Hagmann
  • , Lena Hellström-Westas
  • , Petra Lemmers
  • , Jane Lindschou
  • , Gunnar Naulaers
  • , Wim van Oeveren
  • , Adelina Pellicer
  • , Gerhard Pichler
  • , Claudia Roll
  • , Maria Skoog
  • , Per Winkel
    • Martin Wolf, Christian Gluud

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'A phase II randomized clinical trial on cerebral near-infrared spectroscopy plus a treatment guideline versus treatment as usual for extremely preterm infants during the first three days of life (SafeBoosC): study protocol for a randomized controlled trial.'. Together they form a unique fingerprint.

Medicine and Dentistry

Nursing and Health Professions

Neuroscience